Anesthetic Efficacy Of 4% ArtpharmaDent Versus 2% Mepecaine-L in Extraction of Lower First Primary Molars

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-09-01

Study Completion Date

2019-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

parallel technique will be done where the investigator (will be blinded) will give one type on anesthesia then performing the extraction and evaluating the intraoperative pain ,the same procedure will be done for the other type of anesthesia.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Articaine Versus Lidocaine Buccal Infiltration

NCT05223075

Pain

UNKNOWN PHASE2

Comparing Articaine and Mepivacaine Without Palatal Injection in Pain Assessment During Maxillary Teeth Extraction

NCT03470532

Pain

COMPLETED PHASE4

Self-Reported Pain in Children Submitted to Single Infiltration of Articaine During Primary Molar Extraction

NCT05443009

Dental Pain Anesthesia, Local

COMPLETED PHASE4

Efficiency of Single Buccal Infiltration Versus Buccal and Intrapapillary Infiltration

NCT04458142

Anesthesia, Local

UNKNOWN NA

Comparing Buccal Infiltration and Inferior Alveolar Nerve Block for Extraction of Mandibular Teeth

NCT04294745

Buccal Infiltration Inferior Alveolar Nerve Block Articaine

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Badly Decayed Lower First Primary Molars in Children

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

2% Mepecaine-L

infiltration injection of 2% Mepivacaine

Group Type ACTIVE_COMPARATOR

Mepivacaine 2% Injection

Intervention Type DRUG

infiltration injection of 2% Mepecaine-L

4% Artpharmadent

infiltration injection of 4% Articaine

Group Type EXPERIMENTAL

articaine

Intervention Type DRUG

infiltration injection of 4%artpharmadent

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

articaine

infiltration injection of 4%artpharmadent

Intervention Type DRUG

Mepivacaine 2% Injection

infiltration injection of 2% Mepecaine-L

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Artpharmadent 2% Mepecaine-L

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Children aged 6-8 years.
* Medically fit (ASA I, II).
* Mentally capable of communication.
* Having a mandibular first primary molar tooth that require Extraction.
* Child must give assent prior to participation, as well as parental informed written consent.
* Body weight \>20 kg.
* it should be the first dental treatment to the child

Exclusion Criteria

* Medically and mentally compromised children.
* Children without a history of prolonged bleeding, platelet disorders, hypersensitivity,
* History of significant behavior management problems.
* Patients having active sites of pathosis in the area of injection.
* Patients who had taken analgesics or antibiotics in the 12-hrs preceding the injection.
* Patients allergic to Articaine and/or Mepivacaine and/or sulfur

Minimum Eligible Age

6 Years

Maximum Eligible Age

8 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No